Venous thrombosis: risk factors and management.
During the past 2 decades, the diagnostic and therapeutic approach to deep vein thrombosis (DVT) has greatly evolved. First, the assessment of the clinical probability has gained wide acceptance. Second, novel noninvasive diagnostic tools such as venous compression ultrasonography and D-dimer measurement have become available, drastically reducing the need for invasive tools such as phlebography. Third, new anticoagulant drugs, in particular low-molecular-weight heparins (LMWHs), have become available and have made DVT treatment a lot easier by allowing out-of-hospital management. Several diagnostic algorithms, based on the assessment of clinical probability, D-dimer measurement and venous compression ultrasonography, have shown to be safe in management studies. In addition to improvements in diagnostic algorithms and anticoagulant treatment, compression therapy by elastic stockings to diminish the prevalence of the postthrombotic syndrome has been validated in prospective studies.The dilemma of the need or no need for looking for and treating isolated calf DVT with anticoagulants remains a controversial issue, as do the optimal length and intensity of anticoagulation. In the near future, the emergence of several new, totally synthetic, orally active anticoagulant compounds, such as direct thrombin or factor Xa inhibitors that are presently being tested in clinical studies, could profoundly change the therapeutic approach to DVT.
Righini
Marc
M
Division of Angiology and Hemostasis, Geneva University Hospital, 24 rue Micheli-du-Crest, 1211 Geneva 14, Switzerland. Marc.Righini@hcuge.ch
Bounameaux
Henri
H
D000465:Algorithms; D000925:Anticoagulants / Q000627:therapeutic use*; D020000:Decision Support Systems, Clinical; D006801:Humans; D011379:Prognosis; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D053828:Stockings, Compression; D020246:Venous Thrombosis / Q000175:diagnosis* / Q000628:therapy*
D000925:Anticoagulants